Dr. Pointer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1514 Jefferson Hwy
New Orleans, LA 70121Phone+1 504-842-3336Fax+1 504-842-3884
Summary
- Dr. David Pointer is a surgical oncologist in New Orleans, LA and is affiliated with Ochsner Health. He received his medical degree and completed a residency in General Surgery at Tulane University School of Medicine. He completed a fellowship in Complex General Surgical Oncology at H. Lee Moffitt Cancer Center and Research Institute in Tampa, FL. He is experienced in surgical oncology with specific interest in upper gastrointestinal/foregut, HPB, skin/soft tissue malignancies and minimally-invasive techniques.
Education & Training
- University of South Florida MorsaniFellowship, Complex General Surgical Oncology, 2018 - 2020
- University of South Florida MorsaniFellowship, Surgery, 2020
- Tulane UniversityResidency, Surgery, 2013 - 2018
- Tulane University School of MedicineClass of 2012, MD
- Sewanee: The University of the SouthBS, Economics, Biology, Cum Laude, 2004 - 2008
Certifications & Licensure
- FL State Medical License 2017 - 2026
- LA State Medical License 2016 - 2025
- MS State Medical License 2021 - 2025
- AL State Medical License 2021 - 2024
- American Board of Surgery Surgery
- American Board of Surgery Complex General Surgical Oncology
Publications & Presentations
PubMed
- 25 citationsClinical accuracy and reproducibility of Portrait 3D Surgical Simulation Platform in breast augmentation.Brian Mailey, Andrew Freel, Ryan Wong, David T. Pointer, Kamran Khoobehi
Aesthetic Surgery Journal. 2013-01-01 - 43 citationsMelatonin Represses Metastasis in Her2-Postive Human Breast Cancer Cells by Suppressing RSK2 ExpressionLulu Mao, Whitney Summers, Shulin Xiang, Lin Yuan, Robert T. Dauchy
Molecular Cancer Research. 2016-08-17 - 54 citationsEpigenetic inhibition of the tumor suppressor ARHI by light at night-induced circadian melatonin disruption mediates STAT3-driven paclitaxel resistance in breast cancerShulin Xiang, Robert T. Dauchy, Aaron E. Hoffman, David T. Pointer, Tripp Frasch
Journal of Pineal Research. 2019-09-01
Press Mentions
- Pointer Returns Home to Join Department of Surgery at His Alma MaterOctober 8th, 2021
- Minimally Invasive Surgery Shows Benefit in Colon CancerSeptember 7th, 2021
- Comparing Robotic Surgery to Open EsophagectomiesSeptember 11th, 2021
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: